IN LATE MAY — just before the start of Pride Month — the Trump administration formally announced its intent to allow medical practitioners and health insurers to legally discriminate against transgender people.
A regulation being prepared by the administration would weaken protections against anti-trans discrimination in health care.
Although informed consent models for prescribing hormone replacement therapy are becoming increasingly prevalent, many physicians continue to require an assessment and referral letter from a mental health professional prior to prescription. Drawing on personal and communal experience, the author argues that assessment and referral requirements are dehumanising and unethical, foregrounding the ways in which these requirements evidence a mistrust of trans people, suppress the diversity of their experiences and sustain an unjustified double standard in contrast to other forms of clinical care. Physicians should abandon this unethical requirement in favour of an informed consent approach to transgender care.
Republican Gov. Charlie Baker signed the bill into law after it passed with overwhelming support in the House and Senate.
Evidence shows women are often deemed “overly dramatic” and dismissed by medical professionals, which has deadly consequences.
$1.5 million gift kick-starts sexual, gender minority health equity initiative
A recent study of trans people in the Netherlands provides a sober corrective to this wild speculation. Wiepjes et al. (2018) studied a group of 6,793 trans people who were evaluated at the largest Dutch gender identity clinic from 1972 to 2015…